Prenatal cfDNA Screening Results Indicative of Maternal Neoplasm: Survey of Current Practice and Management Needs

    loading  Checking for direct PDF access through Ovid

Abstract

(Abstracted from Prenat Diagn 2017;37(2):126–132)

The discovery of cell-free fetal DNA (cfDNA) that is free-floating in the serum has led to the development of screening technologies, both in obstetrics and oncology. Circulating cfDNA in the serum of pregnant women is the basis of noninvasive prenatal testing (NIPT).

Related Topics

    loading  Loading Related Articles